U.S. Markets closed

Sorrento Therapeutics, Inc. (SRNE)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.050.00 (0.00%)
At close: 4:00PM EDT
People also watch
NKRGLSADXSTGTXLBIO
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue8,1524,5903,825
Cost of Revenue8111,9502,043
Gross Profit7,3412,6401,782
Operating Expenses
Research Development42,17531,34323,983
Selling General and Administrative16,09820,1329,987
Non Recurring45,00024,013209
Others8451,1572,345
Total Operating Expenses104,11876,64536,524
Operating Income or Loss-96,777-74,005-34,742
Income from Continuing Operations
Total Other Income/Expenses Net33,11965,93812
Earnings Before Interest and Taxes-63,223-12,108-34,730
Interest Expense1,6101,6521,629
Income Before Tax-64,833-13,760-36,359
Income Tax Expense-89636,314-1,702
Minority Interest6,465-4,214-4,214
Net Income From Continuing Ops-60,488-49,852-34,657
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-60,923-45,811-34,657
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-60,923-45,811-34,657